241 related articles for article (PubMed ID: 34418633)
1. The impact of structured diabetes education on glycemic control during Ramadan fasting in diabetic patients in Beni Suef, Egypt.
Nassar M; Ahmed TM; AbdAllah NH; El Sayed El Hadidy K; Sheir RE
Diabetes Metab Syndr; 2021; 15(5):102249. PubMed ID: 34418633
[TBL] [Abstract][Full Text] [Related]
2. Real-world Safety and Effectiveness of Insulin Glargine 300 U/mL in Participants with Type 2 Diabetes Mellitus During the Period of Ramadan in Four Countries (Egypt, Jordan, Lebanon, and Turkey): A Prospective Observational Study.
Hassanein M; Shaltout I; Malek R; Assaad Khalil S; Ballout H; Annabi F; Shereen M
Curr Diabetes Rev; 2024; 20(5):e110823219694. PubMed ID: 37581325
[TBL] [Abstract][Full Text] [Related]
3. Impact of Ramadan Focused Education Program on medications adjustment for patients with type 2 diabetes in a primary health care institution in Saudi Arabia.
Tourkmani AM; Alharbi TJ; Bin Rsheed AM; AlRasheed AN; AlBattal SM; Abdelhay O; Hassali MA; Faya SI; Assiri ES; Al Ghishiayan KI; Alrasheedy AA; Abbas MA
Diabetes Metab Syndr; 2019; 13(1):161-165. PubMed ID: 30641690
[TBL] [Abstract][Full Text] [Related]
4. Impact of provision of optimum diabetes care on the safety of fasting in Ramadan in adult and adolescent patients with type 1 diabetes mellitus.
Alawadi F; Alsaeed M; Bachet F; Bashier A; Abdulla K; Abuelkheir S; Rashid F; Abdulaziz Bin Hussain A; Abdelgadir E; Alsayyah F; Elsayed M; Hassanein M
Diabetes Res Clin Pract; 2020 Nov; 169():108466. PubMed ID: 32971155
[TBL] [Abstract][Full Text] [Related]
5. Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan.
Bravis V; Hui E; Salih S; Mehar S; Hassanein M; Devendra D
Diabet Med; 2010 Mar; 27(3):327-31. PubMed ID: 20536496
[TBL] [Abstract][Full Text] [Related]
6. Fasting during the holy month of Ramadan among older children and adolescents with type 1 diabetes in Kuwait.
Mohamed K; Al-Abdulrazzaq D; Fayed A; El Busairi E; Al Shawaf F; Abdul-Rasoul M; Shaltout AA
J Pediatr Endocrinol Metab; 2019 Aug; 32(8):843-849. PubMed ID: 31318694
[TBL] [Abstract][Full Text] [Related]
7. Outcome of focused pre-Ramadan education on metabolic and glycaemic parameters in patients with type 2 diabetes mellitus.
El Toony LF; Hamad DA; Omar OM
Diabetes Metab Syndr; 2018 Sep; 12(5):761-767. PubMed ID: 29729978
[TBL] [Abstract][Full Text] [Related]
8. Positive impact of pre-Ramadan education on glycemic control and reducing risk of hypoglycemia in type 2 diabetic elderly patients during COVID 19 pandemic.
El Toony LF; Elghazally SA; Hamad DA
Prim Care Diabetes; 2022 Aug; 16(4):581-587. PubMed ID: 35491316
[TBL] [Abstract][Full Text] [Related]
9. Effect of fasting ramadan in diabetes control status - application of extensive diabetes education, serum creatinine with HbA1c statistical ANOVA and regression models to prevent hypoglycemia.
Aziz KM
Recent Pat Endocr Metab Immune Drug Discov; 2013 Sep; 7(3):233-51. PubMed ID: 23964680
[TBL] [Abstract][Full Text] [Related]
10. Safety Assessment of Glucose-Lowering Drugs and Importance of Structured Education during Ramadan: A Systematic Review and Meta-Analysis.
Shiju R; Akhil A; Thankachan S; Tuomilehto J; Al Arouj M; Bennakhi A
J Diabetes Res; 2022; 2022():3846253. PubMed ID: 35242880
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of contextual education for self-management in Thai Muslims with type 2 diabetes mellitus during Ramadan.
Susilparat P; Pattaraarchachai J; Songchitsomboon S; Ongroongruang S
J Med Assoc Thai; 2014 Aug; 97 Suppl 8():S41-9. PubMed ID: 25518292
[TBL] [Abstract][Full Text] [Related]
12. The impact of Ramadan fasting on metabolic profile among type 2 diabetes mellitus patients: A meta-analysis.
Tahapary DL; Astrella C; Kristanti M; Harbuwono DS; Soewondo P
Diabetes Metab Syndr; 2020; 14(5):1559-1570. PubMed ID: 32947756
[TBL] [Abstract][Full Text] [Related]
13. Effect of ramadan fasting on glycemic control and other essential variables in diabetic patients.
Bener A; A Al-Hamaq AOA; Öztürk M; Çatan F; Haris PI; Rajput KU; Ömer A
Ann Afr Med; 2018; 17(4):196-202. PubMed ID: 30588933
[TBL] [Abstract][Full Text] [Related]
14. Optimizing Ramadan fasting: A randomised controlled trial for people with type 2 diabetes during Ramadan applying the principles of the ADA/EASD consensus.
Ibrahim M; Barker MM; Ahmad E; Ahmed A; Annabi FA; Ba-Essa EM; Davies MJ; Houeiss P; Iraqi H; Masood SN; Mimouni-Zerguini S; Shaikh S; Tantawi H; Tuomilehto J
Diabetes Metab Res Rev; 2023 Mar; 39(3):e3604. PubMed ID: 36547366
[TBL] [Abstract][Full Text] [Related]
15. Use of flash glucose monitoring system in assessing safety of the SGLT2 inhibitors during Ramadan fasting in high risk insulin treated patients with type 2 diabetes.
Abdelgadir E; Rashid F; Bashier A; Al Saeed M; Khalifa A; Alawadi F; Hassanein M
Diabetes Metab Syndr; 2019; 13(5):2927-2932. PubMed ID: 31425958
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, randomized trial, including frequent patient-physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study.
Hassanein M; Abdallah K; Schweizer A
Vasc Health Risk Manag; 2014; 10():319-26. PubMed ID: 24920915
[TBL] [Abstract][Full Text] [Related]
17. Is Ramadan fasting safe in type 2 diabetic patients in view of the lack of significant effect of fasting on clinical and biochemical parameters, blood pressure, and glycemic control?
M'guil M; Ragala MA; El Guessabi L; Fellat S; Chraibi A; Chabraoui L; Israili ZH; Lyoussi B
Clin Exp Hypertens; 2008 Jul; 30(5):339-57. PubMed ID: 18633757
[TBL] [Abstract][Full Text] [Related]
18. Vildagliptin therapy and hypoglycaemia in Muslim type 2 diabetes patients during Ramadan.
Devendra D; Gohel B; Bravis V; Hui E; Salih S; Mehar S; Hassanein M
Int J Clin Pract; 2009 Oct; 63(10):1446-50. PubMed ID: 19678856
[TBL] [Abstract][Full Text] [Related]
19. Mitigation of hypoglycemia during Ramadan using the flash glucose monitoring system following dose adjustment of insulin and sulphonylurea in patients taking multiple glucose-lowering therapies (The PROFAST-IT Study).
Elhadd T; Bashir M; Baager KA; Ali HA; Almohannadi DHS; Dabbous Z; Malik RA; Abou-Samra AB;
Diabetes Res Clin Pract; 2021 Feb; 172():108589. PubMed ID: 33316309
[TBL] [Abstract][Full Text] [Related]
20. Diabetes during Ramadan - PRE-approach model: presentation, risk stratification, education.
Hassan A; Meo SA; Usmani AM; Shaikh TJ
Eur Rev Med Pharmacol Sci; 2014; 18(12):1798-805. PubMed ID: 24992624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
